黄病毒科和冠状病毒科病毒侵染中的外泌体研究进展

外泌体是一种在细胞间信息传递和物质运输中起重要作用的细胞外囊泡,它携带来源于宿主细胞的蛋白质、脂质和RNA等物质,并对受体细胞的生理状态产生重要影响.黄病毒科病毒如丙型肝炎病毒和冠状病毒科病毒如新型冠状病毒导致的疾病严重威胁人类健康,深入了解黄病毒科和冠状病毒科病毒与宿主的相互作用,对于筛选治疗的细胞靶点以及外泌体疫苗...     

外泌体在病毒感染诊断和治疗中的作用研究 *

外泌体是多泡体与细胞质膜融合后释放的细胞外囊泡.它们携带有源自分泌细胞的功能性蛋白质,脂质和核酸,能够介导细胞间通信,并在生物体的致病过程中发挥重要作用.当前,对外泌体在病毒感染中的作用机制研究,以及外泌体作为病毒感染诊断和治疗的潜在标志物研究仍处于初级阶段.首先阐述了外泌体的组成和生物学发生机制;然后重点阐述了外泌体在病毒感染中的作用机制,尤其是其在免疫调节中的作用;最后探讨了外泌体作为病毒感染诊断和治疗的潜在标志物的可能性及其应用前景.     

外泌体在病毒感染诊断和治疗中的作用研究

外泌体是多泡体与细胞质膜融合后释放的细胞外囊泡。它们携带有源自分泌细胞的功能性蛋白质、脂质和核酸,能够介导细胞间通信,并在生物体的致病过程中发挥重要作用。当前,对外泌体在病毒感染中的作用机制研究,以及外泌体作为病毒感染诊断和治疗的潜在标志物研究仍处于初级阶段。首先阐述了外泌体的组成和生物学发生机制;然后重点阐述了外泌体在病毒感染中的作用机制,尤其是其在免疫调节中的作用;最后探讨了外泌体作为病毒感染诊断和治疗的潜在标志物的可能性及其应用前景。     

RNA病毒利用外泌体促进病毒感染的研究进展

外泌体是一种由细胞主动向胞外分泌的囊泡类小体,因其能在细胞间传递蛋白、脂类和核酸等分子,而被认为是一种新的重要的细胞间通讯方式。RNA病毒,如HIV-1、HCV等,作为一类重要的病原体,一直影响着全人类的健康。近来的研究发现,病毒能够利用外泌体的某些相关功能促进其复制与传播。然而,对外泌体与病毒感染的相关研究才刚刚起步,尚有很多方面并未被详细认知,所要研究的内容还有很多。本文主要总结了外泌体在一些RNA病毒感染中的促进作用及其可能的机制,以期让大家了解RNA病毒与外泌体之间已有的相互关系。     

外泌体功能的相关研究进展

外泌体是由不同细胞分泌的膜性囊泡,它从细胞内的释放受到多种因素的影响,可以通过其独特的分子特征被鉴别。随着对外泌体逐渐深入的研究,科学家们发现,外泌体不仅能够对宿主免疫系统产生影响,而且在病毒感染宿主的过程中扮演了重要角色。外泌体与肿瘤的发生发展密切相关,但是具体作用机制不甚清楚,值得进一步的研究。     

外泌体在肝纤维化中的作用

外泌体(exosomes)是一种能被大多数细胞分泌的微小膜泡,是具有脂质双层膜结构的细胞外囊泡。现认为外泌体是细胞外囊泡(extracellular vesicles, EVs)的一种亚群。研究表明,外泌体是细胞间信息传递的一种载体。肝脏既可以分泌外泌体,同时也是其他组织细胞产生的外泌体的作用靶点,且肝内与肝外来源的外泌体与肝纤维化的形成、发生、发展均有密切联系。本文主要就外泌体在肝纤维化相关疾病中的作用及外泌体与肝纤维化指标之间的关系进行综述。     

外泌体和miRNA在川崎病中的研究进展

外泌体(exosome)是一类径在30～150 nm之间、具有脂质双层膜结构的微小囊泡。生物体内多数细胞都可以分泌外泌体,外泌体可在细胞之间起传递遗传信息的作用,其携带的蛋白质、DNA、RNA等可被受体细胞所摄取并发挥作用。MiRNA作为内源基因编码单链核苷酸分子,可参与体内基因的表达调控,同时在外泌体中也广泛存在。川崎病(Kawasaki disease)是一种急性自身免疫性疾病,目前miRNA在川崎病中的研究已被广泛认可。外泌体在各类疾病中的研究越来越多,但在川崎病的研究中仍然处于初级阶段,外泌体中可以包含多种miRNA而不受破坏,所以外泌体中的miRNA与川崎病的关联性可以进一步探讨。本综述讨论了外泌体的作用和临床意义以及在川崎病诊断与治疗中的优点和缺陷,并提出了外泌体及miRNA可能在其中发挥的作用。     

microRNA与病毒感染

microRNA是一类新近发现的由20-23个核苷酸构成的非编码RNA分子,它在生命进程中起着重要作用.病毒的复制和繁殖依赖于宿主细胞,而且对细胞环境的变化敏感.研究表明宿主和病毒都可以编码microRNA,病毒可通过小RNA介导的干扰作用影响宿主细胞,也能利用自身的"独特战略"改变宿主细胞从而满足自己生存的需求,所以,宿主与病毒间存在microRNA-mRNA相互作用的机制.尽管时microRNA与病毒感染的关系研究时间不长,但目前的研究结果为我们理解病毒和宿主之间的相互作用提供了一条途径,并为寻找病毒感染的生物标志物和治疗方法提供了新的思路.     

外泌体在病毒感染中的研究进展

外泌体(exosome)是细胞向胞外分泌的一种囊泡,直径约40~100 nm。外泌体与免疫、肿瘤以及病毒类疾病的发生发展有着密切的联系,已成为上述领域内的研究热点。文章就外泌体在病毒感染中的研究进展作一综述。     

外泌体提取及保存技术研究进展

外泌体是多种活细胞经过"内吞–融合–外排"等一系列过程主动向胞外分泌的纳米级双层膜结构小囊泡,广泛存在于血液和尿液等生物体液中。因其携带着多种蛋白质、核酸和脂质等生物活性分子,所以外泌体不仅在细胞间物质交换和信息传递中发挥重要作用,而且对疾病诊断、预后预测和治疗管理等均具有提示意义。外泌体的高效提取、分离和完整保存是研究其在机体内生物学作用和功能的重要前提,也是制约基于外泌体的临床检测技术和治疗载体技术的关键。该综述将针对目前国内外外泌体提取和保存领域的最新研究进展加以综述,并对其特点进行对比和分析,以促进外泌体研究方法的标准化,以及相关技术的研发和应用拓展。     

Glycosylation in viral hepatitis

BackgroundThe interaction between hepatitis viruses and host cells is regulated by glycans exposed on the surfaces of human and viruses cells. As the biosynthesis and degradation of human glycoproteins take place at the highest level in the liver, the changes in glycosylation of serum proteins may potentially be useful in the diagnosis of liver pathology. On the other hand, specific alterations in viruses envelope glycans could cause large changes in the entry process of hepatitis viruses into a host cells.Scope of reviewUnique alterations in glycosylation of specific proteins can be detected in HBV and HCV infected patients especially with confirmed fibrosis/cirrhosis. On the other hand, viral envelope proteins that bind to host cells are glycosylated. These glycosylated proteins play a key role in recognition, binding and penetration of the host cells. In this review we summarized the knowledge about significance of glycosylation for viral and host factors.Major conclusionsGlycosylation changes in single serum glycoproteins are noticed in the sera of patients with viral hepatitis. However, a more specific biomarker for the diagnosis of chronic hepatitis than that of a single glycosylated molecule is systemic investigation of complete set of glycan structures (N-glycome). Glycans play important roles in the viral biology cycle especially as a connecting element with host receptors.General significanceThe interaction between virus glycoproteins and cellular receptors, which are also glycoproteins, determines the possibility of virus penetration into host cells. Therefore these glycans can be the targets for the developing of novel treatment strategies of viral hepatitis.     

植物抗病毒分子机制

在与植物病毒的长期斗争中,植物进化出多种抗病毒机制,其中RNA沉默和R基因介导的病毒抗性是最受人们关注的两种机制.一方面,RNA沉默是植物抵抗病毒侵染的重要手段.植物在病毒侵染过程中可形成病毒来源的双链RNA,经过DCL蛋白的切割、加工形成sRNA,与AGO蛋白结合形成RISC指导病毒RNA的沉默,用于清除病毒.相应地,病毒在与植物的竞争中进化出RNA沉默抑制子,抑制宿主RNA沉默系统以逃避宿主RNA沉默抗病毒反应,增强致病能力.另一方面,植物也进化出R基因介导植物对包括病毒在内的多类病原的抗性.R蛋白直接或间接识别病毒因子,通过一系列的信号转导途径激活植物防御反应,限制病毒的进一步侵染.对植物抗病毒的研究有助于人们对植物抗病分子基础的理解,有重要的科学意义和潜在应用价值.本文综述了植物抗病毒分子机制的重要进展.     

Exosomes Released from Rabies Virus-Infected Cells May be Involved in the Infection Process

Exosomes are cell-derived vesicles that are secreted by many eukaryotic cells. It has recently attracted attention as vehicles of intercellular communication. Virus-infected cells release exosomes, which contain viral proteins, RNA, and pathogenic molecules. However, the role of exosomes in virus infection process remains unclear and needs to be further investigated.In this study, we aimed to evaluate the effects of exosomes on rabies virus infection. OptiPrep~(TM) density gradient centrifugation was used to isolate exosomes from rabies virus-infected cell culture supernatants. A rabies virus G protein enzyme-linked immunosorbent assay and acetylcholinesterase activity assays were performed to verify the centrifugation fractions. Exosomes were then characterized using transmission electron microscopy and Western blotting. Our results showed that rabies virus infection increased the release of exosomes. Treatment with GW4869 and si-Rab27 a, two exosomal secretion inhibitors, inhibited exosome release. Furthermore, the inhibitors reduced the levels of extracellular and intracellular viral RNA. These data indicated that exosomes may participate in the viral infection process. Moreover, our results establish a basis for future research into the roles of exosomes in rabies virus infection and as potential targets for developing new antiviral strategies.     

Caspase cleavage of viral proteins, another way for viruses to make the best of apoptosis

Viral infection constitutes an unwanted intrusion that needs to be eradicated by host cells. On one hand, one of the first protective barriers set up to prevent viral replication, spread or persistence involves the induction of apoptotic cell death that aims to limit the availability of the cellular components for viral amplification. On the other hand, while they completely depend on the host molecular machinery, viruses also need to evade the cellular responses that are meant to destroy them. The existence of numerous antiapoptotic products within the viral kingdom proves that apoptosis constitutes a major threat that should better be bypassed. Among the different strategies developed to deal with apoptosis, one is based on what viruses do best: backfiring the cell on itself. Several unrelated viruses have been described to take advantage of apoptosis induction by expressing proteins targeted by caspases, the key effectors of apoptotic cell death. Caspase cleavage of these proteins results in various consequences, from logical apoptosis inhibition to more surprising enhancement or attenuation of viral replication. The present review aims at discussing the characterization and relevance of this post-translational modification that adds a new complexity in the already intricate host–apoptosis–virus triangle.     

Virus-cell interactions: impact on cytokine production, immune evasion and tumor growth

The outcome of a viral infection ranges from benign to fatal with the clinical pictures being very diverse. This is largely due to the virus-cell interactions that occur in the infected organism. Rapidly after infection, cells initiate a first line of defense against the virus. The cells sense viruses through several mechanisms. Among these the ability to respond to accumulation of double-stranded RNA has been particularly well studied and seems to be of importance. On the other hand, the close co-existence of virus and host has allowed viruses to develop mechanisms to down-modulate the initial reaction or to exploit this proinflammatory response in its own advance. This review describes how virus infections affect cellular signal transduction and the mechanisms through which certain viruses modulate this response to dampen the immune response or prevent cell death.     

Cross-talking between autophagy and viral infection in mammalian cells

Autophagy is a cellular process in degradation of long-lived proteins and organelles in the cytosol for maintaining cellular homeostasis, which has been linked to a wide range of human health and disease states, including viral infection. The viral infected cells exhibit a complicated cross-talking between autophagy and virus. It has been shown that autophagy interacts with both adaptive and innate immunity. For adaptive immunity, viral antigens can be processed in autophagosomes by acidic proteases before major histocompatibility complex (MHC) class II presentation. For innate immunity, autophagy may assist in the delivery of viral nucleic acids to endosomal TLRs and also functions as a part of the TLR-or-PKR-downstream responses. Autophagy was also reported to suppress the magnitude of host innate antiviral immunity in certain cases. On the other hand, viruses has evolved many strategies to combat or utilize the host autophagy for their own benefit. In this review we discussed recent advances toward clarifying the cross-talking between autophagy and viral infection in mammalian cells.     

siRNA, miRNA and HIV: promises and challenges

Small interfering RNA (siRNA) and microRNA (miRNA) are small RNAs of 18-25 nucleotides (nt) in length that play important roles in regulating gene expression. They are incorporated into an RNA-induced silencing complex (RISC) and serve as guides for silencing their corresponding target mRNAs based on complementary base-pairing. The promise of gene silencing has led many researchers to consider siRNA as an anti-viral tool. However, in long-term settings, many viruses appear to escape from this therapeutical strategy. An example of this may be seen in the case of human immunodeficiency virus type-1 (HIV-1) which is able to evade RNA silencing by either mutating the siRNA-targeted sequence or by encoding for a partial suppressor of RNAi (RNA interference). On the other hand, because miRNA targeting does not require absolute complementarity of base-pairing, mutational escape by viruses from miRNA-specified silencing may be more difficult to achieve. In this review, we discuss stratagems used by various viruses to avoid the cells' antiviral si/mi-RNA defenses and notions of how viruses might control and regulate host cell genes by encoding viral miRNAs (vmiRNAs).     

New molecular mechanisms of virus-mediated carcinogenesis: oncogenic transformation of cells by retroviral structural protein Envelope

RNA tumor viruses as classified in Retroviruses have been isolated and identified to induce tumors in a variety of animals including chickens, mice, and rats, or even in human in the last 100 years, since the first one has been reported in 1908. The RNA tumor viruses have been historically classified into two groups, acute transforming RNA tumor viruses and nonacute RNA tumor viruses. Acute transforming RNA tumor viruses are basically replication-defective and rapidly induce tumors by expressing the viral oncogenes captured from cellular genome in host cells. The first oncogene derived from Rous sarcoma virus was the src non-receptor tyrosine kinase, which has been identified to play the significant roles for signal transduction. On the other hand, nonacute RNA tumor viruses, which consist of only gag, pro, pol, and env regions but do not carry oncogenes, are replication-competent and could activate the cellular proto-oncogenes by inserting the viral long terminal repeat close to the proto-oncogenes to induce tumors with a long incubation period, as is termed a promoter insertion. These molecular mechanisms have been thought to induce tumors. However, very recently several reports have described that the retroviral structural protein Envelope could directly induce tumors in vivo and transform cells in vitro. These are very unusual examples of native retroviral structural proteins with transformation potential. In this review we look back over the history of oncogenic retrovirus research and summarize recent progress for our understanding of the molecular mechanisms of oncogenic transformation by retrovirus Envelope proteins.     

Viral miRNAs exploiting the endosomal-exosomal pathway for intercellular cross-talk and immune evasion

The class of persistent gamma-herpesviruses has developed a variety of strategies that exploit host-cell regulatory pathways to ensure a long-lasting, well-balanced infection of their host. However when these pathways are deregulated, an otherwise harmless infection can lead to disease including cancer. We recently demonstrated that the human herpes virus 4 (HHV4) also known as Epstein-Barr virus (EBV), encodes for small regulatory non-coding microRNAs (miRNAs) that can be transferred from an infected cell to uninfected neighboring cells. Upon arrival these miRNAs are functional in the recipient cell, in that they are able to down regulate specific target genes. These secreted miRNAs are transported to recipient cells via small nano-sized vesicles (known as exosomes) that are of endosomal origin, formed as intraluminal vesicles (ILV) inside multivesicular bodies (MVB). One question that needs to be addressed is how viral miRNAs are sorted into these exosomes. Mature miRNAs, including those of viral origin, are loaded into RNA-induced silencing complexes (RISC) for gene silencing via blocking mRNA translation and/or initiating mRNA decay. Recent insights indicate that cytoplasmic RNA granules rich in RISC complexes are closely associated with endosomes. In fact, selective components of RISC, including GW182 and Argonaut proteins, miRNAs and mRNAs are present in exosomes. Thus miRNA function, mRNA stability and exosome-mediated intercellular communication converge at the level of endosomes. Since endosomes can be considered as key intracellular cross-roads that regulate communication of cells with their exterior, including neighboring cells, it is perhaps not surprising that viruses have found means to exploit this pathway to their benefit. Little is known however, how and if (micro) RNA species are specifically sorted into ILVs and what (micro)RNA-binding proteins are involved. Here we discuss recent developments relating to intracellular trafficking and function of miRNA-containing protein complexes that EBV may exploit for promoting or restricting miRNAs sorting into exosomes for intercellular regulatory functions. This article is part of a Special Issue entitled: MicroRNAs in viral gene regulation.     

Roles of HIV-1 auxiliary proteins in viral pathogenesis and host-pathogen interactions

INTRODUCTION In addition to the prototypical retroviral Gag, Pol, and Env proteins, HIV-1 produces six additional proteins, i.e., Tat, Rev, Nef, Vif, Vpr and Vpu (Fig. 1, adapted from [1]). While Tat and Rev are required for viral replication, Nef, Vif, V…